Subject : Understanding ACS patient– Presentation, Treatment goals and Management (APTeM Study)
Acute coronary syndrome refers to a group of diseases in which blood flow to the heart is decreases. Acute coronary syndromes (ACS) encompass a spectrum of conditions that include patients presenting with recent changes in clinical symptoms or signs, with or without changes on electrocardiogram (ECG) and with or without acute elevations in cardiac troponin concentrations. Patients presenting with suspected ACS may eventually receive a diagnosis of acute myocardial infarction (AMI) or unstable angina (UA).
Management of ACS starts from the point when diagnosis of ACS is established. The treatment in acute phase consists of oxygen supplementation, nitrates, pain relief by opioids, platelet inhibition by oral P2Y12 receptor antagonists and beta blockers. This is often followed by reperfusion therapy.
LDL-C has been recognized as a causal factor for atherosclerotic disease. Landmark trials showed that LDL-c-lowering agents, such as statins, significantly reduce the incidence of adverse ischemic events in patients with CAD. Secondary prevention after ACS is central to increase quality of life and to decrease morbidity and mortality. This should start as early as possible after the index event.
The purpose of this survey is to understand the presentation, treatment goals and management of ACS patients.
We invite you to participate in this survey. On acceptance, you will need to fill the survey questionnaire form provided.
We would encourage you to carefully fill all available information to the fullest in the questionnaire.
If you agree to participate in the said survey, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.
|